My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June 2016
POLICY AND ADVOCACY
Senate Bill Would Increase Funding for Antibiotic Resistance, But Impose Cuts Elsewhere
The Senate committee that oversees federal spending has approved a bill for health programs that would bring good news and bad news for ID. 
 
The committee recommended a Fiscal Year 2017 increase of $2 billion (+6.2% over FY 2016) for the National Institutes of Health (NIH) and a decrease of $118 million (-1.6% from FY 2016) for the Centers for Disease Control and Prevention (CDC). 
 
The committee recommended a slight increase of $43 million for antimicrobial resistance programs, which is a positive development for implementation of the National Action Plan for Combating Antibiotic-Resistant Bacteria, building on a $380 million increase provided last year and bringing the total federal expenditure in this area to nearly $1 billion. 
 
The bill largely flat funds programs in the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention as well as in the National Center for Immunization and Respiratory Diseases. However, the bill recommends cuts to CDC sexually transmitted infections programs as well as tuberculosis efforts of 3.2% and 3.5% respectively. 
 
The committee’s bill also included a provision, supported by the advocacy of nearly 500 IDSA members, which would examine the evaluation and management billing codes used to reimburse physicians through Medicare to make certain that proper value is assigned. 
 
The House of Representatives is expected to produce its version of a health spending bill before the chamber recesses for the summer in mid-July. IDSA will continue its advocacy in the House to secure robust funding for infectious diseases programs.


< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
FDA Alerts Health Facilities of M. Chimaera Due to Heater-cooler devices; CDC Continued Updates on Zika Testing
Guidelines Survey: Please Take 10 Minutes to Share Your Feedback
CLINICAL PRACTICE MANAGEMENT
Antimicrobial Stewardship Programs via Telehealth
IDSA Webinar Explains CMSís Proposed New Payment Program
POLICY AND ADVOCACY
IDSA Continues to Drive Legislative Progress on Antimicrobial Resistance
Zika Funding Remains in Limbo
Senate Bill Would Increase Funding for Antibiotic Resistance, But Impose Cuts Elsewhere
HIVMA Endorses the Equality Act
GLOBAL HEALTH
Science Speaks Covers UN Meeting on Ending AIDS
EDUCATION AND RESOURCES
IDWeek Mentorship Program
IDSA Foundation Offers Three Research Awards in 2016
HIVMA Medical Student Program Aims to Inspire Careers in HIV
Support IDSA Foundation Through CFC
ABIM Seeks Your Input on MOC Exams
New CDC and Mass General Resource Helps Travelers Stay Healthy
FROM THE PRESIDENT
Antimicrobial Resistance: Persistence Pays Off With This Strategic Priority
TOP STORIES
New IDSA Guideline on Diagnosis and Treatment of Aspergillosis
OPAT Handbook Now Available in Interactive, Digital Format
Donít Miss the Meeting Everyone Will be Talking About at IDWeek 2016!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.